scholarly journals ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR LIMIT OF N-NITROSODIMETHYLAMINE BY LC-MS/MS OF EMPAGLIFLOZIN, LINAGLIPTIN AND METFORMIN HCL EXTENDED-RELEASE TABLETS

2021 ◽  
Vol 10 (5) ◽  
pp. 3534-3537
Author(s):  
Narayan Shrivas
Keyword(s):  
Mobile Phase ◽  
High Performance ◽  
Extended Release ◽  
Method Development ◽  
Atmospheric Pressure Chemical Ionization ◽  
Pharmaceutical Research ◽  
Metformin Hydrochloride ◽  
Technical Requirement ◽  
Buffer Solution ◽  
Liquid Chromatography Tandem Mass

As a result of the devotion of The Limit of N-Nitrosodimethylamine (NDMA), a rapid and selective LC/MS/MS technique was created and validated for Empagliflozin, Linagliptin, and Metformin Hydrochloride Extended-Release Tablets. The ionization mode of Atmospheric pressure chemical ionization (APCI) was used with high-performance liquid chromatography-tandem mass spectrophotometry (LC-MS/MS). Separation of N-Nitrosodimethylamine (NDMA) was performed on Inertsil ODS-4 (250 mm X 4.6 mm), 5μm column with a run time of 40 minutes. A mixture of Methanol and Buffer solution (630 mg of ammonium format into 1000 mL of purified water) in the ratio of (10:90, v/v) was used as the mobile phase A. A mixture of acetonitrile and methanol comprised the mobile phase B in the ratio of (50:50) % v/v. Analytes were extracted from Empagliflozin, Linagliptin, and Metformin Hydrochloride Extended-Release Tablets. According to the International council for Harmonization of technical requirement for Pharmaceuticals for Human Uses (ICH) standards, the accuracy, precision, selectivity, recovery, and stability of the method have been validated. Over a concentration range of 0.4 -3.6 ng/mL, the technique exhibited linearity. for N- Nitrosodimethylamine of Empagliflozin, Linagliptin, and Metformin Hydrochloride Extended-Release Tablets with an acceptable correlation coefficient applies (1/X2) linear regression with weights A pharmaceutical study can benefit from this method because it is simple, fast, precise, and accurate, making it ideal for pharmaceutical research.

scholarly journals Bio-Analytical Method Development of Repaglinide Drug Delivery Systems

2019 ◽  
Vol 9 (6) ◽  
pp. 140-142
Author(s):  
B. Ramu ◽  
Kaushal K Chandrul ◽  
P. Shanmuga Pandiyan
Keyword(s):  
Phosphate Buffer ◽  
Extraction Method ◽  
Mobile Phase ◽  
High Performance ◽  
Drug Delivery Systems ◽  
Method Development ◽  
Extraction Efficiency ◽  
Ultraviolet Spectroscopy ◽  
Rabbit Plasma ◽  
Solvent Extraction Method

A sensitive, specific and rapid high-performance liquid chromatography-ultraviolet spectroscopy method was developed and successfully validated to estimate the repaglinide in rabbit plasma. The solvent extraction method was used for  repaglinide from serum by using ethyl acetate and 0.1N HCl. The mobile phase consists of acetonitrile: phosphate buffer pH 4.0 at 60:40 %v/v with 1% triethylamine at flow rate of 0.8ml/min and at fixed wavelength of 254nm. On ten minutes of run time, repaglinide was retention at 7.4min. The extraction efficiency 95% for repaglinide. The intra-day and inter-day precision was in the terms of %RSD less than 1.76%. The developed method was validated and proposed method is useful for pharmacokinetics studies.  Keywords: Anti-diabetics, HPLC,Methanol,Phosphate buffer, Repaglinide

scholarly journals Method Development and Validation for Quantification of Potential Genotoxic Impurity, PyCl in Lansoprazole Hydrochloride using Liquid Chromatography Combined with Mass Spectrometry

2021 ◽  
Vol 33 (5) ◽  
pp. 1165-1168
Author(s):  
C. Purushotham Reddy ◽  
G. Venkateswara Rao ◽  
K. Ramakrishna ◽  
K.M.V. Narayana Rao
Keyword(s):  
Mass Spectrometry ◽  
Liquid Chromatography ◽  
Mobile Phase ◽  
High Performance ◽  
Method Development ◽  
Limit Of Detection ◽  
Gradient Elution ◽  
Solution Stability ◽  
Selective Ion Monitoring ◽  
Acquity Uplc

A sensitive and robust high performance liquid chromatography combined with tandem mass spectrometry (LC-MS/MS) method was developed and validated for the determination of potential genotoxic impurity (PGI), 2-(chloromethyl)-3-methyl-4-(2,2,2-trifluoroethoxy)-pyridine hydrochloride (PyCl) in lansoprazole as per ICH Q2 guideline. In this method, PyCl and lansoprazole were well-separated from each other on Acquity UPLC BEH-C18 column (50 × 4.6 mm × 1.7 μ) in a gradient elution mode with the mobile phase consisting of 0.1% formic acid in water (mobile phase-A) and acetonitrile (mobile phase-B) at a flow rate of 0.4 mL/min. For the quantitation of Py-Cl, selective ion monitoring (SIM) mode was used with m/z 240 ion in LC-MS method. The validated method was found to be precise, accurate and linear from the range of LOQ level to 150% with respect to sample concentration and the correlation co-efficient was found to be 0.998. Limit of detection (LOD) and limit of quantifications (LOQ) were found to be 0.000012 and 0.000004 mg/mL, respectively. The validated method was found to be sensitive and the recoveries were found to be well within the range from 83.4% to 95.9% for Py-Cl. Further, the solution stability was also established as the same were found to be stable upto 24 h.

scholarly journals RP-HPLC method development and validation for simultaneous estimation of efonidipine hydrochloride ethanolate and telmisartan in their synthetic mixture

2021 ◽  
pp. 190-195
Author(s):  
Grishma H Patel ◽  
Shreya D Adeshra ◽  
Dhananjay B Meshram
Keyword(s):  
Mobile Phase ◽  
High Performance ◽  
Method Development ◽  
High Performance Liquid Chromatographic ◽  
Reversed Phase ◽  
Hplc Method ◽  
Simultaneous Estimation ◽  
Quality Control Laboratory ◽  
Efficient Option ◽  
Liquid Chromatographic

A Novel, selective, accurate and rapid Reversed Phase High Performance Liquid Chromatographic (RPHPLC) method for the analysis of Efonidipine Hydrochloride Ethanolate and Telmisartan in binary mixture has been developed and validated. The chromatographic system consisted of a Phenomenex Kinetex ® 5µ C18 Size: 150 * 4.6mm column and the separation was achieved by using ambient temperature with a mobile phase containing mobile Phase Acetonitrile:25mM Phosphate Buffer pH 4.9 (45:55). The samples were monitored at 253 nm for detection at a flow rate of 1.0 mL/min and the retention time was about 7.77 and 4.10 mins for Efonidipine Hydrochloride Ehanolate and Telmisartan respectively. The calibration curve was linear over the concentration range 5-30 and 10-60 ?g/mL for Efonidipine Hydrochloride Ehanolate and Telmisartan respectively. The proposed method is accurate in the range of 99.75% - 100.10% recovery and precise (%RSD of intraday variation and % RSD of inter day variation were found to be within the acceptance criteria). Therefore, this method can be used as a more convenient and efficient option for the analysis of Efonidipine Hydrochloride Ehanolate and Telmisartan in Quality control laboratory.

scholarly journals Effect of mobile phase buffer pH on separation selectivity of some isoquinoline alkaloids in reversed-phase systems of Pressuriz

2015 ◽  
Vol 26 (3) ◽  
pp. 45-49
Author(s):  
Ewelina Kopciał ◽  
Beata Polak ◽  
Rafał Pietraś ◽  
Paulina Mączka ◽  
Tadeusz H. Dzido
Keyword(s):  
Mobile Phase ◽  
High Performance ◽  
Reversed Phase ◽  
Retardation Factor ◽  
Isoquinoline Alkaloids ◽  
Buffer Solution ◽  
Separation Selectivity ◽  
Phase Systems ◽  
Ph Range ◽  
Layer Chromatography

Separation of some isoquinoline alkaloids (narcotine, chelidonine, dihydrocodeine, cinchonine, berberine, cinchonidine, papaverine, apomorphine) has been investigated with pressurized planar electrochromatography (PPEC) and high-performance thin-layer chromatography (HPTLC) in reversed-phase systems. The mobile phase consisted of acetonitrile and aqueous buffer (disodium phosphate and citric acid). The influence of the mobile phase buffer pH on migration distance (PPEC) and retardation factor (HPTLC) of the solutes has been investigated and compared. The results show different separation selectivity in both PPEC and HPTLC systems especially at pH range of buffer solution of the mobile phase that facilitates ionization of the solutes investigated.

Bioanalytical Method Development and Validation of Naproxen: Application to Bioequivalence Studies

2017 ◽  
Vol 8 (2) ◽  
Author(s):  
Senthil Rajan Dharmalingam ◽  
Srinivasan Ramamurthy ◽  
Sai Siddhardh ◽  
M. D. Basheerudhin
Keyword(s):  
Human Plasma ◽  
Mobile Phase ◽  
High Performance ◽  
Method Development ◽  
Diclofenac Sodium ◽  
Pharmacokinetic Studies ◽  
Chromatography Method ◽  
Method Development And Validation ◽  
Liquid Chromatography Method ◽  
Development And Validation

A new selective and sensitive high-performance liquid chromatography method was developed for the quantification of Naproxen in human plasma using diclofenac sodium asinternal standard (IS). Chromatographic separation was achieved on aPhenomenex GEMINI C18 (150 x 4.6 mm, 5 mm) column. The mobile phase consists of a mixture of Acetonitrile: 0.5% Triethylamine buffer (50:50; v/v) and the pH of the mobile phase was adjusted to 3.5 by 85 % orthophosphoric acid. Flow rate of mobile phase was 1 mL/min.Detection was performed at 230nm. The calibration curve was linear over the concentration range from 10 to 120µg/mL. The detection (LOD) and quantification (LOQ) limits were 10 ng/mL and 25 ng/Ml respectively. The method was validated for accuracy, precision, specificity, robustness, and detection and quantification limits, in accordance with ICH guidelines.The developed method for the determination of Naproxen from human plasma has been found accurate, precise, selective, and suitable for the bioequivalence and pharmacokinetic studies.

oncepts in development of fast, simple, stability indicating HPLC method for analysis of atorvastatin related compounds in tablets

2018 ◽  
Vol 7 (4) ◽  
pp. 450-457
Author(s):  
Marjan Piponski ◽  
Tanja Bakovska Stoimenova ◽  
Magdalena Piponska ◽  
Gordana Trendovska Serafimovska
Keyword(s):  
Development Strategy ◽  
Mobile Phase ◽  
High Performance ◽  
Method Development ◽  
Separation Efficiency ◽  
Gradient Elution ◽  
Hplc Method ◽  
Peak Resolution ◽  
Stepwise Gradient ◽  
Run Time

New, fast, simple and mild conditioned High Performance Liquid Chromatography (HPLC) method for determination of atorvastatin and its 7 main specified impurities, as well as unspecified impurities that might possibly appear, was developed. Chromatographic runs last between 25 and 40 minutes, with simple stepwise gradient elution. The main accent in our method development strategy was focused on mobile phase, composed of simple binary system composed of phosphate buffer and acetonitrile, at pH 4.1, without use of tetrahydrofuran, ion-pair reagents, trifluoroacetic acid and other modifiers with high Ultraviolet (UV) cut-off like absorptive acetate or formiate buffers or amines. With our concept of mobile phase, different columns from myriad were tested, with different efficiency, dimensions and properties, which resulted in different separation efficiency and run time. The best results, concerning essential critical peak resolution, run time length including column preparation and equilibration and column backpressure, were achieved with: YMC C18 Triart 150mm x 4.6mm, 3µm (YMC America, Inc.), afterwards with Nucleodur 100-3-C18ec 250mm x 4.6mm, 3µm (Macherey-Nagel GmbH & Co., Germany), Waters Symmetry C18 250mm x 4.6mm, 5µm (Waters, USA) and Superspher C18e 125mm x 4mm, 4µm (Merck, Darmstadt, Germany). All this columns achieve excellent results regarding obligated critical resolution between atorvastatin impurity B and atorvastatin (according to European Pharmacopoeia),1 or in some cases between atorvastatin impurity B and atorvastatin impurity C, to be minimum about 1.5, in both cases.

High Performance HPLC-UV Method Development and Validation for Sulfadoxine from its Potential Interfering Impurities

2021 ◽  
Vol 08 ◽  
Author(s):  
Nayan S. Gadhari ◽  
Jayram V. Gholave ◽  
Suyog S. Patil ◽  
Ajay R. Patil ◽  
Kiran F. Shelke ◽  
...  
Keyword(s):  
Mobile Phase ◽  
High Performance ◽  
Method Development ◽  
Degradation Products ◽  
Drug Product ◽  
Ich Guidelines ◽  
Daunting Task ◽  
Method Development And Validation ◽  
The Stability ◽  
Development And Validation

Objective: To address the separation of interfering potential impurities associated with the drug is always a daunting task. We present the method validation and quantitative determination of sulfadoxine (SUL), an anti-malarial drug with most important interfering impurities present pharmaceutical dosages and in bulk samples using HPLC-UV method. Methods: The UV detection was obtained at 270 nm and SUL is separated on Sunfire C18 (25 cm x 4.6 mm x 5 µ m) column at 45°C with flow rate of 1.0 mL/min in a mobile phase (CH3COOH:CH3CN). The stress testing (acidic/basic/oxidative) was performed using HPLC for SUL and its impurities showing the highly efficient separation peaks between degradant and drug product. Results: The developed method was found to be highly accurate and sensitive in regulation with ICH guidelines. Also, it was found to be free from interference from degradation products which allows the stability indicating capability of developed HPLC-UV method for SUL for validation in bulk drugs. Conclusion: The main advantages of the present method; (a) Separation achieved in 30 minutes, (b) MS compatible mobile phase renders this developed method can be directly adapted to LC-MS without any major modifications in near future, and (c) separation of twelve impurities on Sunfire C18 column. The CFs (correction factors) had been calculated for all the impurities. It was found to be 1.6 (IMP IX), 1.70 (IMP XI) and in between 0.8-1.3 for all other impurities. The LOD of the developed method for all the analytes were in the range of 0.05 to 0.11 μg/mL and the LOQ values were in the range of 0.17 to 0.36 μg/mL.

Sign in / Sign up

Export Citation Format

Share Document